Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Strategic Asset Allocation Index
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Strategic Asset Allocation Index of 29.1% as of December 2022. Strategic assets (PP&E of ₫393.80 Billion plus long-term investments of ₫-) total ₫393.80 Billion, measured against net assets of ₫1.36 Trillion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See DBD net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Binh Dinh Pharmaceutical and Medical Equipment JSC Strategic Asset Allocation Index (2020–2022)
This chart shows how Binh Dinh Pharmaceutical and Medical Equipment JSC's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 29.1%, representing strategic assets of ₫393.80 Billion against net assets of ₫1.36 Trillion VND. For live market cap and overall valuation, see DBD stock market capitalisation.
Annual Strategic Asset Allocation Index for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Binh Dinh Pharmaceutical and Medical Equ (DBD) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (VND) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 29.1% | ₫393.80 Billion | ₫393.80 Billion | ₫- | ₫1.36 Trillion | ▼ -3.5 pp |
| 2021 | 32.5% | ₫371.06 Billion | ₫371.06 Billion | ₫- | ₫1.14 Trillion | ▼ -3.6 pp |
| 2020 | 36.2% | ₫357.47 Billion | ₫357.47 Billion | ₫- | ₫988.63 Billion | — |